Autonomix Medical (AMIX) Return on Capital Employed (2024 - 2025)

Autonomix Medical's (AMIX) quarterly Return on Capital Employed came in at 236.48% in Q4 2025, down 6891.0% year-on-year from 3.48% in Q4 2024, and up 2.68% on a QoQ basis from 242.98% in Q3 2025.

Autonomix Medical (AMIX) Return on Capital Employed (2024 - 2025) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Return on Capital Employed data on file, last reported at 236.48% in Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 6891.0% year-over-year to 236.48% in Q4 2025; TTM through Dec 2025 was 236.48%, a 6891.0% decrease from a year earlier, with the FY2025 full-year figure at 146.69%, up 12929.0% from the prior year.
  • Return on Capital Employed for Q4 2025 stood at 236.48%, up from 242.98% in the prior quarter.
  • Over the last five years, Return on Capital Employed for AMIX reached as high as 126.34% in Q1 2025 and fell as low as 249.04% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.61%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.24%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 8.02%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 11.13%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 24.24%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.38%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.30%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Autonomix Medical 1.03 Mn 1.03 Mn - -236.48%

Historic Data

Download Data
DateValue
Dec 31, 2025 -236.48%
Sep 30, 2025 -242.98%
Jun 30, 2025 -164.81%
Mar 31, 2025 -126.34%
Dec 31, 2024 -167.57%
Sep 30, 2024 -219.63%
Jun 30, 2024 -185.80%
Mar 31, 2024 -249.04%